Additional L-Carnitine Reduced the Risk of Hospitalization in Patients with Overt Hepatic Encephalopathy on Rifaximin

Background: Data regarding the additional effect on the recurrence of hepatic encephalopathy (HE) after oral L-carnitine administration are scarce. Objective: This study aimed to assess the additional effects of L-carnitine in patients who were receiving rifaximin for HE. Methods: This randomized st...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Digestive diseases (Basel) 2022-01, Vol.40 (3), p.313-321
Hauptverfasser:	Kubota, Kousuke, Uojima, Haruki, Shao, Xue, Iwasaki, Shuichiro, Hidaka, Hisashi, Wada, Naohisa, Nakazawa, Takahide, Shibuya, Akitaka, Kako, Makoto, Koizumi, Wasaburo
Format:	Artikel
Sprache:	eng
Schlagworte:	Liver: Research Article
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!